Zobrazeno 1 - 10
of 1 960
pro vyhledávání: '"Post-Transplant Lymphoproliferative Disorder"'
Publikováno v:
Radiology Case Reports, Vol 19, Iss 6, Pp 2168-2182 (2024)
Primary central nervous system post-transplant lymphoproliferative disease (PCNS-PTLD) is a rare subset of post-transplant lymphoproliferative disorder (PTLD) isolated to the CNS without nodal or extra-nodal organ involvement [1,2]. PCNS-PTLD occurs
Externí odkaz:
https://doaj.org/article/a88ad66f2bd143ec9562b197748d6dcb
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2780-2795 (2024)
Epstein–Barr virus-related post-transplantation lymphoproliferative disorder (EBV-PTLD) is a serious complication following hematopoietic stem cell transplantation (HSCT). A pre-emptive strategy using rituximab, which aims to manage patients early
Externí odkaz:
https://doaj.org/article/60b84cc37e82470795a3dc991a4f32f2
Autor:
Kaleb Veit, DO, Tahuanty Peña, MD, MS, Julia Klesney-Tait, MD, PhD, Eric Mou, MD, Umar Farooq, MD
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100101- (2024)
Chimeric antigen receptor T-cell therapy (CAR-T) has been used to treat refractory post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant patients, including heart, kidney, liver, intestine, and pancreas. We report the use of C
Externí odkaz:
https://doaj.org/article/623aeb9d284540dc9ab60f84e30defda
Autor:
Toh, Jiaying 1, 2, 3, 4, 16, Reitsma, Andrea J. 1, Tajima, Tetsuya 1, Younes, Sheren F. 5, Ezeiruaku, Chimere 1, Jenkins, Kayla C. 1, Peña, Josselyn K. 1, 2, Zhao, Shuchun 5, Wang, Xi 1, Lee, Esmond Y.Z. 6, Glass, Marla C. 1, Kalesinskas, Laurynas 3, 4, 7, Ganesan, Ananthakrishnan 3, 4, 8, Liang, Irene 1, Pai, Joy A. 2, 5, Harden, James T. 1, 2, Vallania, Francesco 3, 4, Vizcarra, Edward A. 1, Bhagat, Govind 9, Craig, Fiona E. 10, Swerdlow, Steven H. 11, Morscio, Julie 12, Dierickx, Daan 13, Tousseyn, Thomas 12, 14, Satpathy, Ansuman T. 5, 15, Krams, Sheri M. 1, 15, Natkunam, Yasodha 5, Khatri, Purvesh 3, 4, 15, 17, ∗, Martinez, Olivia M. 1, 15, 18, 19, ∗∗
Publikováno v:
In Cell Reports Medicine 17 December 2024 5(12)
Autor:
Lei Jin, Di Lu, Feng Yan, Jinkun Han, Penghu Wei, Yiqiang Zhou, Yaming Wang, Yongzhi Shan, Guoguang Zhao
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundPrimary central nervous system post-transplant lymphoproliferative disorder (PCNS-PTLD) is a rare condition, posing diagnostic and treatment challenges, with histological biopsy essential for diagnosis. Standardized treatment protocols are
Externí odkaz:
https://doaj.org/article/dc60b5c856904fa98a7d83f3491028d2
Publikováno v:
Viruses, Vol 16, Iss 8, p 1294 (2024)
The acquisition or reactivation of Epstein–Barr virus (EBV) after allogeneic Hematopoietic Stem Cell Transplant (HSCT) can be associated with complications including the development of post-transplant lymphoproliferative disorder (PTLD), which is a
Externí odkaz:
https://doaj.org/article/0d963fd3f1464553a23a8d1b541e7711
Publikováno v:
Transplantology, Vol 4, Iss 3, Pp 178-184 (2023)
Splenosis is a benign, acquired condition characterized by the auto-implantation of focal deposits of splenic tissue throughout the peritoneal cavity, most commonly occurring after splenic injury and/or splenectomy. Post-Transplant Lymphoproliferativ
Externí odkaz:
https://doaj.org/article/0da841e34b384ffaa12af86e2b2991cd
Autor:
Nick Veltmaat, Yujie Zhong, Filipe Montes de Jesus, Geok Wee Tan, Johanna A. A. Bult, Martijn M. Terpstra, Pim G. N. J. Mutsaers, Wendy B. C. Stevens, Rogier Mous, Joost S. P. Vermaat, Martine E. D. Chamuleau, Walter Noordzij, Erik A. M. Verschuuren, Klaas Kok, Joost L. Kluiver, Arjan Diepstra, Wouter J. Plattel, Anke van den Berg, Marcel Nijland
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-5 (2023)
Abstract Diagnosing post-transplant lymphoproliferative disorder (PTLD) is challenging and often requires invasive procedures. Analyses of cell-free DNA (cfDNA) isolated from plasma is minimally invasive and highly effective for genomic profiling of
Externí odkaz:
https://doaj.org/article/9e6d8c46862e487885e9719b47a06740
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 848-851 (2023)
Abstract Posttransplant lymphoproliferative disease (PTLD) is a potentially life‐threatening complication of hematopoietic cell transplantation. With improvements in Epstein‐Barr virus (EBV) monitoring and supportive care, PTLD incidence has decr
Externí odkaz:
https://doaj.org/article/600dde767cca41b5b014fc3a315a5bc5
Autor:
Alessandra Zaccardelli, Fabienne M. Lucas, Ann S. LaCasce, Anil K. Chandraker, Jamil R. Azzi, Simon G. Talbot
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
Vascularized composite allotransplantation (VCA) is an emerging field in transplant surgery. Despite overall positive outcomes, VCA confers risk for multiple complications related to the procedure and subsequent immunosuppression. Post-transplant lym
Externí odkaz:
https://doaj.org/article/5f40cdc5cf9d413cb981f7543aad29b8